首页> 外国专利> Genes of il-12p40 subunit mutated for improving the activity of il-12 and thereof for dna vaccine adjuvant

Genes of il-12p40 subunit mutated for improving the activity of il-12 and thereof for dna vaccine adjuvant

机译:il-12p40亚基的基因被突变以提高il-12及其对dna疫苗佐剂的活性

摘要

The present invention relates to the IL-12p40 subunit mutant gene which can produce IL-12 (interleukin 12) of human and mouse origin with high activity, the expression vector including above mutant gene and the use of them to DNA vaccine adjuvant. Particularly, it relates to IL-12p40 mutant gene which inhibits the secretion of IL-12p40 but normally secretes active IL-12p70 by making mutation at Asn-222 (human) or Asn-220 (mouse) amino acid of IL-12p40, which acts as a competitive inhibitor of active form of IL-12, IL-12p70. Therefore, the IL-12p40 mutant gene of the present invention can be useful for DNA vaccination and gene therapy against various diseases, for example, AIDS, hepatitis C or hepatitis B, cancer, influenza, tuberculosis and malaria, which essentially require cellular immune responses for their therapy.
机译:本发明涉及可以高活性产生人和小鼠来源的IL-12(白介素12)的IL-12p40亚基突变基因,包括上述突变基因的表达载体及其在DNA疫苗佐剂中的用途。特别是涉及通过抑制IL-12p40的Asn-222(人)或Asn-220(小鼠)氨基酸的突变而抑制IL-12p40的分泌,但通常分泌活性IL-12p70的IL-12p40突变基因。作为IL-12,IL-12p70活性形式的竞争性抑制剂。因此,本发明的IL-12p40突变体基因可用于DNA接种和针对各种疾病的基因治疗,所述疾病例如AIDS,C型或B型肝炎,癌症,流行性感冒,结核病和疟疾,这些疾病基本上需要细胞免疫应答。为他们的治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号